Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis

Journal of Clinical Investigation

Volumn 108, Issue 5, 2001, Pages 739-747

  Chitnis, Tanuja ^a   Najafian, Nader ^b   Benou, Christina ^a   Salama, Alan D ^b   Grusby, Michael J ^c   Sayegh, Mohamed H ^b   Khoury, Samia J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; STAT4 PROTEIN; STAT6 PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM DISEASE; INFLAMMATORY INFILTRATE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ADOPTIVE TRANSFER; ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CYTOKINES; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE TARGETING; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN; STAT4 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TRANS-ACTIVATORS;

EID: 0034789247     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200112563     Document Type: Article

References (62)

1. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity
2. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis
3. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: Dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin; tumor necrosis factor alpha and tumor necrosis factor beta
4. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo
5. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain
6. Experimental autoimmune encephalomyelitis in IL-4-deficient mice
7. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
8. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice
9. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
10. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
11. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse
12. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis
13. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15
14. Cytokine receptor signaling mechanisms
15. Cytokine receptors: Structures and signal transduction
16. Essential role of Stat6 in IL-4 signalling
17. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
18. Interleukin 12 signaling in T helper type I (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4
19. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
20. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
21. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells
22. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence
23. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo
24. CD28-independent induction of experimental autoimmune encephalomyelitis
25. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
26. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization
27. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
28. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta
29. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymphoid cells
30. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines
31. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways
32. Regulation o falloantigen-mediated T-cell proliferation by endogenous interferon-gamma: Implications for long-term allograft acceptance
33. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma
34. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
35. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes
36. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB
37. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
38. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-gamma production
39. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis
40. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
41. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
42. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis
43. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
44. Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: A critical step in the differentiation of pathogenic auroreactive T cells
45. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4
46. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocyres
47. The role of chemokine receptors in primary, effector, and memory immune responses
48. Chemokines - Chemotactic cytokines that mediate inflammation
49. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)
50. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin
51. Mig and IP-10: CXC chemokines that target lymphocytes
52. Human Mig chemokine: Biochemical and functional characterization
53. Cutting edge: Differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4
54. Signal transducer and activator of transcription 6 controls chemokine production and t helper cell type 2 cell trafficking in allergic pulmonary inflammation
55. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells
56. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
57. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
58. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
59. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
60. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells
61. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
62. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo